Proteome Sciences Plc (PRM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH124418D
- Pages: 49
- November 2018
- Total Views:1156
- Region : Europe
- GlobalData
- Equity Research Report
Details
Summary
Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery and provision of data insights. It maps the protein expressions and modifications that help define processes for improving research outcomes. The company detects and characterizes deferentially expressed proteins using its proprietary technologies in biological samples for prognostic, diagnostic and therapeutic applications. The company develops novel biomarkers for various disease areas such as central nervous system diseases including Alzheimer's, Huntington's, stroke and traumatic brain injury; oncology comprising lung, breast, colorectal and esophageal cancers; and cardiac diseases, for diagnostic and treatment applications. It has facilities in London and Frankfurt. Proteome Sciences is headquartered in London, England, the UK.
Proteome Sciences Plc (PRM)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Proteome Sciences Plc, Medical Devices Deals, 2012 to YTD 2018 9
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 11
Proteome Sciences Enters Into Co-Development Agreement With CHDI Foundation 13
Equity Offering 14
Proteome Sciences Raises USD1.3 Million in Second and Final Tranche of Private Placement of Shares 14
Proteome Sciences Raises USD2.8 Million in First Tranche of Private Placement of Shares 15
Proteome Sciences to Raise USD4 Million in Private Placement of Shares 16
Proteome Sciences Announces Private Placement Of Shares For USD 8.3 Million 17
Proteome Sciences Completes Private Placement Of Common Stock For USD 2.4 Million 18
Proteome Sciences Plc-Key Competitors 19
Proteome Sciences Plc-Key Employees 20
Proteome Sciences Plc-Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 23
Financial Announcements 23
Jul 24, 2018: Proteome Sciences: Interim results for the six months ended 30 June 2018 23
Apr 24, 2018: Proteome Sciences: Preliminary results for the year ended 31 December 2017 26
Jul 25, 2017: Proteome Sciences: Interim Results for the Six Months Ended 30 June 2017 31
Mar 28, 2017: Proteome Sciences Announces Preliminary results for the year ended 31 December 2016 Notice of AGM 32
Corporate Communications 43
Apr 24, 2018: Proteome Sciences Appoints Richard Dennis As Board Director 43
Aug 01, 2017: Proteome Sciences: Directorate changes 44
Apr 03, 2017: Proteome Sciences Announces Appointment of Richard Dennis as Chief Commercial Officer 45
Legal and Regulatory 46
Oct 18, 2017: Proteome Sciences: GCLP Accreditation and Trading Update 46
Other Significant Developments 47
Nov 06, 2018: Proteome Sciences: Trading update confirmation of preferred provider status 47
Jun 12, 2017: Proteome Sciences: New Registered Address 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
List Of Figure
List of Figures
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Proteome Sciences Plc, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Proteome Sciences Plc, Medical Devices Deals, 2012 to YTD 2018 9
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 11
Proteome Sciences Enters Into Co-Development Agreement With CHDI Foundation 13
Proteome Sciences Raises USD1.3 Million in Second and Final Tranche of Private Placement of Shares 14
Proteome Sciences Raises USD2.8 Million in First Tranche of Private Placement of Shares 15
Proteome Sciences to Raise USD4 Million in Private Placement of Shares 16
Proteome Sciences Announces Private Placement Of Shares For USD 8.3 Million 17
Proteome Sciences Completes Private Placement Of Common Stock For USD 2.4 Million 18
Proteome Sciences Plc, Key Competitors 19
Proteome Sciences Plc, Key Employees 20
Proteome Sciences Plc, Other Locations 21
Proteome Sciences Plc, Subsidiaries 21
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Proteome Sciences Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery and provision of data insights. It maps the protein expressions and modifications that help define processes for improving research outcomes. The company detects and characterizes deferentially expressed proteins using its proprietary technologies in biological samples for prognostic, diagnostic and therapeutic applications. The company develops novel biomarkers for various disease areas such as central nervous system diseases including Alzheimer's, Huntington's, stroke and traumatic brain injury; oncology comprising lung, breast, colorectal and esophageal cancers; and cardiac diseases, for diagnostic and treatment applications. It has facilities in London and Frankfurt. Proteome Sciences is headquartered in London, England, the UK.
Proteome Sciences Plc (PRM)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Proteome Sciences Plc, Medical Devices Deals, 2012 to YTD 2018 9
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 11
Proteome Sciences Enters Into Co-Development Agreement With CHDI Foundation 13
Equity Offering 14
Proteome Sciences Raises USD1.3 Million in Second and Final Tranche of Private Placement of Shares 14
Proteome Sciences Raises USD2.8 Million in First Tranche of Private Placement of Shares 15
Proteome Sciences to Raise USD4 Million in Private Placement of Shares 16
Proteome Sciences Announces Private Placement Of Shares For USD 8.3 Million 17
Proteome Sciences Completes Private Placement Of Common Stock For USD 2.4 Million 18
Proteome Sciences Plc-Key Competitors 19
Proteome Sciences Plc-Key Employees 20
Proteome Sciences Plc-Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 23
Financial Announcements 23
Jul 24, 2018: Proteome Sciences: Interim results for the six months ended 30 June 2018 23
Apr 24, 2018: Proteome Sciences: Preliminary results for the year ended 31 December 2017 26
Jul 25, 2017: Proteome Sciences: Interim Results for the Six Months Ended 30 June 2017 31
Mar 28, 2017: Proteome Sciences Announces Preliminary results for the year ended 31 December 2016 Notice of AGM 32
Corporate Communications 43
Apr 24, 2018: Proteome Sciences Appoints Richard Dennis As Board Director 43
Aug 01, 2017: Proteome Sciences: Directorate changes 44
Apr 03, 2017: Proteome Sciences Announces Appointment of Richard Dennis as Chief Commercial Officer 45
Legal and Regulatory 46
Oct 18, 2017: Proteome Sciences: GCLP Accreditation and Trading Update 46
Other Significant Developments 47
Nov 06, 2018: Proteome Sciences: Trading update confirmation of preferred provider status 47
Jun 12, 2017: Proteome Sciences: New Registered Address 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
List Of Figure
List of Figures
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Proteome Sciences Plc, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Proteome Sciences Plc, Medical Devices Deals, 2012 to YTD 2018 9
Proteome Sciences Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 11
Proteome Sciences Enters Into Co-Development Agreement With CHDI Foundation 13
Proteome Sciences Raises USD1.3 Million in Second and Final Tranche of Private Placement of Shares 14
Proteome Sciences Raises USD2.8 Million in First Tranche of Private Placement of Shares 15
Proteome Sciences to Raise USD4 Million in Private Placement of Shares 16
Proteome Sciences Announces Private Placement Of Shares For USD 8.3 Million 17
Proteome Sciences Completes Private Placement Of Common Stock For USD 2.4 Million 18
Proteome Sciences Plc, Key Competitors 19
Proteome Sciences Plc, Key Employees 20
Proteome Sciences Plc, Other Locations 21
Proteome Sciences Plc, Subsidiaries 21
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Proteome Sciences Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 130 | 
December 2020
Page 130 | December 2020
Page 131 | November 2020
Page 95 | November 2020
Page 96 | August 2020